1Friedenberg F,JensenG, Gujral N, et al. Serumalbumin is pre- dictive of 30 day survival after pepeutaneous endoscopic gastro- stomy. JPEN, 1997,21 (1) : 72-74.
5Chang KC, Leung CC. The best approach to reintroducing tu- berculosis treatment after hepatotoxicity is still open to de bate. Clin Infect Dis, 2010,51 (3) : 366-368.
5Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
6Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.
7Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997,26,664-669.
8Danan G, Benichou C, Flahault A. Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet. Gastroenterol Clin Biol, 1993,17 ( 5 pt 2 ) : H22-H24.
9Iwasa M ,Zeniya M,Kumagi T,et al. Modified diagnostic criteria of drug-induced liver injury proposed by the intemational consensus meeting, Hepatogastroenteroloty,2005,52:869-874.
10Durand F, Jebrak G, Pessayre D, et al. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf, 1996,15 : 394-405.
